🤯 Have you seen our AI stock pickers’ 2024 results? 84.62%! Grab November’s list now.Pick Stocks with AI

Should Aurora Cannabis Inc. (TSX:ACB) Stock Be in Your Portfolio Today?

Published 2000-12-31, 07:00 p/m
Should Aurora Cannabis Inc. (TSX:ACB) Stock Be in Your Portfolio Today?
DGE
-
STZ
-

The spectacular rise of the marijuana sector has captured the attention of investors in Canada and abroad.

In just a few years, fledgling start-ups that struggled to find financing now have major global corporations beating down their doors to get a foothold in the disruptive segment. Competition is intense, and Aurora Cannabis (TSX:ACB) has emerged as one of the leaders.

Let’s take a look at the Edmonton-based marijuana company to see if it deserves to be on your buy list.

Growth

Consolidation has been the name of the game, and Aurora Cannabis has certainly played its part, gobbling up at least 10 other companies in an effort to position itself to be a major player in both the Canadian and European medical marijuana markets, with an eye on the recreational opportunities to come.

The largest and most notable deals included the all-stock purchases of CanniMed in early 2018 and the recently closed acquisition of MedReleaf. Scale is critical to success in the cannabis segment, as companies need to have the ability to meet demand from the provinces as Canada launches its recreational market.

Aurora now has more than 570,000 kg of funded production capacity, making it a leader in the space.

Partnerships

Aurora continues to build partnerships in the industry, and investors are speculating on a potential deal with a major international beverage company in the wake of the recent move by Constellation Brands (NYSE:STZ) to boost its stake in Canopy Growth to 38%.

Rumours are swirling that global spirits giant Diageo (LON:DGE) is looking to find a dance partner in the Canadian space, and Aurora would certainly be one of the top candidates, given the company’s strong position in both Canada and Europe.

The report that Diageo was in talks with three Canadian companies recently sent share prices soaring in the sector. Aurora jumped from a 2018 closing low of $5.34 on August 14 to above $9, as investors piled in on the hopes of a huge premium, similar to the one received by Canopy Growth.

Valuation

At the time of writing, Aurora trades for $9 per share, putting the market capitalization at roughly $8.8 billion. That’s a lofty price by any measure, and the incredible valuation is the reason investors have to be careful when looking at Aurora or any of its peers.

Should you buy?

Owning any of the marijuana stocks today is risky, given the massive run-up in the stock prices. The long-term potential is certainly appealing, but investors should prepare for ongoing volatility. In fact, I wouldn’t be surprised to see a healthy round of profit taking once the Canadian recreation market actually launches.

In the case of Aurora, the 70% surge since the middle of August is likely overdone, especially if a major deal with a beverage company doesn’t pan out. At this point, I would look for other investment opportunities.

Fool contributor Andrew Walker has no position in any stock mentioned.

This Article Was First Published on The Motley Fool

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.